BME Madrid

ORYZON GENOMICS, S.A.

ISIN ES0167733015Filings at the CNMV

At a glance

Most recent filing on February 27, 2021 — a sale by Tamara Maes on Feb 26, 2021.

We hold 1 visible filing, going back to February 26, 2021.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

All 1 shown

This page is free to read, and it stops after 1 row. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Tamara Maes Proprietary board member
€3,570,000Open-market sale
TradedFeb 26, 2021FiledFeb 27, 2021

Short positions

All short positions

Net short positions of 0.5% or more in ORYZON GENOMICS, S.A. that are open today, as the regulator publishes them. Together they come to 0.60% of the shares. Positions below 0.5% are not published, so the real total can be higher.

1 open position, together 0.60%. The holders and their history are part of the subscription.

Source: Comisión Nacional del Mercado de Valores (CNMV), net short positions, as published on October 30, 2026, shown as published. This information is available free of charge at www.cnmv.es.